Anebulo Pharmaceuticals, Inc.

NasdaqCM:ANEB 주식 보고서

시가총액: US$62.2m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Anebulo Pharmaceuticals 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Richie Cunningham

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간2.2yrs
이사회 평균 재임 기간3.4yrs

최근 관리 업데이트

Recent updates

Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 22
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Feb 18
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Jul 03
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 07
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Nov 19
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Anebulo Pharmaceuticals to launch private investment in public equity financing

Sep 26

Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03

Sep 09

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 28
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 15
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Nov 04
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Anebulo Pharmaceuticals reports FQ3 results

Jun 21

CEO

Richie Cunningham (53 yo)

less than a year

테뉴어

Mr. Richard Anthony Cunningham, also known as Richie, is Chief Executive Officer and Director of Anebulo Pharmaceuticals, Inc. since October 2023. He served as Chief Executive Officer and Director at Tyme...


리더십 팀

이름위치테뉴어보상소유권
Joseph Lawler
Founder & Chairman4.3yrsUS$11.00k46.27%
$ 28.8m
Kenneth Cundy
Chief Scientific Officer2.2yrsUS$495.63k0%
$ 0
Richard Cunningham
CEO & Directorless than a year데이터 없음데이터 없음
Daniel George
Principal Accounting Officerless than a year데이터 없음데이터 없음
Scott Anderson
Head of Investor Relations & Public Affairs2.5yrs데이터 없음데이터 없음

2.2yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 관리: ANEB 의 관리팀은 경험 ( 2.1 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Joseph Lawler
Founder & Chairman4.3yrsUS$11.00k46.27%
$ 28.8m
Richard Cunningham
CEO & Directorless than a year데이터 없음데이터 없음
Bimal Shah
Independent Directorless than a year데이터 없음데이터 없음
Kenneth Lin
Lead Independent Director3.4yrsUS$1.00k0%
$ 0
Areta Kupchyk
Independent Director3.3yrsUS$11.00k0%
$ 0
Jason Aryeh
Independent Director3.3yrsUS$21.00k0%
$ 0
Nathaniel Calloway
Independent Director1.8yrsUS$79.75k데이터 없음
Aron English
Independent Director4.1yrsUS$1.00k17.95%
$ 11.2m
Andrew Monte
Member of Scientific Advisory Board3.5yrs데이터 없음데이터 없음
Arjun Chanmugam
Member of Scientific Advisory Board3.5yrs데이터 없음데이터 없음

3.4yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 이사회: ANEB 의 이사회경험(평균 재직 기간 3.3 년)으로 간주됩니다.